Audited Results of the Company for the Quarter and Financial Year ended 31.03.2025.

Revenue growth above 20%Profit growth above 25%EBITDA margin expansionDebt to equity above the thresholdResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.8%Reaction day

₹76.89

prior close

₹76.50

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.6%-2.4% vs market

Pesticides & Agrochemicals peers, median of 24sector-0.1%-1.7% vs sector

On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 1.7 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.0

10m

+1.3

15m

+0.7

30m

+2.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.8+0.6-2.4-0.1-1.7

Next day

+9.2+0.5+8.7+0.4+8.9

+1.8+0.8+1.0+1.0+0.8

+2.9+1.2+1.7+1.2+1.7

+4.8+1.5+3.4+0.3+4.5

+1.4+1.6-0.1+0.8+0.7

+0.2+1.8-1.6+1.2-1.0

15d

+69.0+3.3+65.7+2.2+66.8

+34.5+3.1+31.4+6.7+27.8

+58.7+2.3+56.4+16.7+42.0

+49.7+0.2+49.5+6.0+43.6

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Bhaskar Agrochemicals posted strong FY25 results with revenue from operations rising about 35.8% to Rs. 9,050.60 lakhs (from Rs. 6,664.53 lakhs in FY24). Profit after tax more than doubled to Rs. 389.70 lakhs (from Rs. 174.18 lakhs), translating to EPS of Rs. 7.48 vs Rs. 3.34 earlier. Q4 standalone revenue stood at Rs. 2,231.17 lakhs with PAT of Rs. 73.50 lakhs. EBITDA margin expanded modestly to around 10% (from ~9.2%). Statutory auditor R. Kankaria & Uttam Singhi issued an unmodified opinion on the results. The Board also approved hikes in remuneration of MD and JMD/CFO from Rs. 8 lakh to Rs. 15 lakh per month plus 5% of PAT as commission, and appointed new internal and secretarial auditors.

Likely market impact

Strong topline growth and more-than-doubled PAT signal improving business momentum for shareholders, though total borrowings of ~Rs. 2,028 lakhs against equity of ~Rs. 1,775 lakhs keeps the balance sheet leveraged and operating cash flow shrank sharply to Rs. 104 lakhs (from Rs. 392 lakhs) due to higher receivables and inventory.